Results released Monday from the Zambia-South Africa TB and AIDS Reduction (ZAMSTAR) program study demonstrate that household counseling – defined as the unpacking of concerns about TB and HIV within households and facilitating prompt diagnosis and treatment – significantly reduced tuberculosis (TB) prevalence. Twenty-four communities across Zambia and South Africa’s Western Cape Province participated in […]
Evelyne Kibuchi is a senior tuberculosis (TB) advocacy officer at the Kenya AIDS NGOs Consortium (KANCO), a national umbrella organization of civil society groups in Kenya that collaborate for resource mobilization for TB and HIV. Kibuchi set the stage for her presentation at the Union World Conference on Lung Health in France on Saturday by […]
Zaheld Islam of the International HIV/AIDS Alliance in the Ukraine shared his organization’s work on TB/HIV integration at a Saturday session of the Union World Conference on Lung Health in France. The Alliance is a Global Fund to Fight AIDS, Tuberculosis and Malaria sub-grantee in the Ukraine with resources from both TB and HIV grants. […]
An oral abstract symposium featured a number of presentations on this broad topic at the Union World Conference on Lung Health Friday. What follows is a snapshot of several of them: Successfully tested but not enrolled in HIV care, missed opportunities for TB patients in rural Zambia S. Muvuma reported on a study that followed […]
Jan Gheuens, Acting Director of the TB program at the Bill & Melinda Gates Foundation (BMGF) informed a packed audience at the International Conference of Lung Health of key changes in the Foundation’s strategy on tuberculosis. The goal of the revamped strategy is to accelerate a reduction in TB incidence, which Gheuens described as more […]
College students, people living with AIDS, and community members held a “pool party” outside of Merck’s laboratories in Boston Friday, to speak out about the company’s hesitation to join the Medicines Patent Pool (MPP) – a two-year-old organization that works with drug companies to create licenses that allow generic drug companies to produce their patented […]
At the Union World Conference on Lung Health Thursday, the Global Fund to Fight AIDS, Tuberculosis and Malaria hosted a forum that showcased civil society tuberculosis (TB) advocacy efforts and outlined the Global Fund’s work to ensure the inclusion of civil society in country-level processes related to Fund grant-making. Jeremiah Muhwa Chakaya from Kenya […]
The National Institute of Allergy and Infectious Diseases (NIAID) is set to close out the HPTN 058 study, a Phase III clinical trial that started in 2007 and was tasked with evaluating whether or not administering opiate dependence medication, combined with drug and HIV risk-reduction counseling, can prevent HIV infection and death among opiate-dependent injection […]
U.S. Agency for International Development (USAID) Director Rajiv Shah hosted a press conference Wednesday at the White House announcing a new aspect of their “Famine, War, Drought” or FWD campaign – together with the Ad Council and other partners – to bring visibility to the challenges taking place in the Horn of Africa and inviting […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]